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Molecular diversity of surface receptors has been
hypothesized to provide a mechanism for selective
synaptic connectivity. Neurexins are highly diver-
sified receptors that drive the morphological and
functional differentiation of synapses. Using a single
cDNA sequencing approach, we detected 1,364
unique neurexin-a and 37 neurexin-b mRNAs pro-
duced by alternative splicing of neurexin pre-mRNAs.
This molecular diversity results from near-exhaustive
combinatorial use of alternative splice insertions in
Nrxn1a and Nrxn2a. By contrast, Nrxn3a exhibits
several highly stereotyped exon selections that
incorporate novel elements for posttranscriptional
regulation of a subset of transcripts. Complexity of
Nrxn1a repertoires correlates with the cellular com-
plexity of neuronal tissues, and a specific subset of
isoforms is enriched in a purified cell type. Our anal-
ysis defines the molecular diversity of a critical syn-
aptic receptor and provides evidence that neurexin
diversity is linked to cellular diversity in the nervous
system.
INTRODUCTION
The morphological and functional diversity of neurons and the
reproducibility of neuronal connectivity are some of the most
fascinating aspects of nervous systems. It has long been postu-
lated that molecular recognition cues might impart a specific
identity on each class of neurons (Sperry, 1963; Nelson et al.,
2006; Shen and Scheiffele, 2010; Zipursky and Sanes, 2010).
However, the total number of neuronal cells and the multitude
of recognizable neuronal subclasses raise the question: To
what extent can such cellular diversity be matched by molecular
identifiers? Work from the past 2 decades uncovered multiple
gene families that undergo substantial molecular diversification
and encode receptors that contribute to the development of
neuronal connectivity (Ushkaryov et al., 1992; Kohmura et al.,386 Neuron 84, 386–398, October 22, 2014 ª2014 Elsevier Inc.1998; Schmucker et al., 2000; Chen and Maniatis, 2013;
Schreiner et al., 2014). However, the cellular logic and actual
molecular diversity of such highly diversified receptors in the
mammalian nervous system remain to be understood.
Alternative splicing provides a powerful mechanism to expand
the molecular coding power of genomes. For example, through
combinatorial use of alternative splice insertions, tens of thou-
sands of Drosophila Down syndrome cell adhesion molecule
(DSCAM) isoforms are generated that engage in exclusively ho-
mophilic interactions (Schmucker et al., 2000; Wojtowicz et al.,
2004). In the mammalian nervous system, neurexins represent
a gene family with the potential to generate substantial molecular
diversity through combinatorial use of splice insertions at multi-
ple segments of the premessenger RNA (pre-mRNA) (Tabuchi
and Su¨dhof, 2002; Baudouin and Scheiffele, 2010). Neurexins
localize to neuronal synapses and play a critical role in their for-
mation and functional differentiation (Dean et al., 2003; Missler
et al., 2003; Graf et al., 2004; Chih et al., 2006; Taniguchi et al.,
2007). Many of the alternatively spliced segments modify pro-
tein-protein interaction interfaces in the neurexin structure, and
several such insertions have been shown to control interaction
with neurexin ligands (Boucard et al., 2005; Chih et al., 2006;
Arac¸ et al., 2007; Chen et al., 2008; Koehnke et al., 2008; Siddiqui
et al., 2010; Uemura et al., 2010). Genetic manipulation of alter-
native splicing at alternatively spliced segment 4 (AS4) in Nrxn3
results in specific defects in synaptic transmission and plasticity
(Aoto et al., 2013). Thus, alternative splicing has, indeed, a pro-
found impact on neurexin protein function in the mammalian
nervous system. However, alternative splicing also amplifiesmo-
lecular diversity of Neurexins in noncoding mRNA sequences.
The alternatively spliced segment 5 (AS5) in Nrxn3 is one of the
most variable sites and has the potential to extensively diversify
the 30 untranslated region (30 UTR) of secreted forms of Nrxn3.
Thus, alternative splicing of neurexins not only regulates cell sur-
face interactions with diverse synaptic ligands but may also
regulate temporal and spatial expression of certain neurexin
isoforms.
The two key aspects shaping activity and functionality of
highly diversified receptors are (1) the actual diversity expressed
in the nervous system and (2) the extent to which molecular
diversity maps onto defined neuronal cell types. Conventional
sequencing and PCR-based methods have been applied in the
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Molecular Diversity of Neurexinspast to demonstrate that various insertions can indeed be incor-
porated at alternatively spliced segments and that there is some
preferential usage of sites across different brain areas (Iijima
et al., 2011, 2014; Ehrmann et al., 2013). However, these
methods fail to assess combinatorial alternative splicing events
in single mRNA molecules. Thus, the actual number of isoforms
and the coding power of neurexins in the mammalian brain are
unknown. The challenge with interrogating combinatorial alter-
native splicing events is to develop workflows that produce suf-
ficiently long single molecule reads while providing sufficient
sequencing depth for statistical power in the analysis (Metzker,
2010; Au et al., 2013). For DSCAMs, this was elegantly solved
using a circularization-assisted multisegment sequence method
where bar-coded circularized fragments of DSCAM could be
subjected to Illumina sequencing (Sun et al., 2013). The size of
Nrxn mRNAs precludes such an analysis for this gene family,
calling for an alternative approach able to properly handle the
large span of these genes. A recent study (Treutlein et al.,
2014) applied Pacific Biosciences (PacBio) single molecule
real-time sequencing (Eid et al., 2009) to neurexins and provided
evidence for combinatorial use of splice insertions in the simpler
beta-neurexin isoforms, which exhibit only limited molecular
diversity. However, for Nrxna, the main drivers of neurexin di-
versity, it was not possible to achieve sufficient long-range
sequencing depth to conduct rigorous evaluations of isoform
numbers or of quantitative and combinatorial use of splice
insertions.
Here, we report a detailed quantitative analysis of Nrxna mo-
lecular diversity, based on single molecule mRNA sequencing
and computational mapping. We achieved coverage of about
370,000 full-length Nrxna transcripts. We demonstrate near-
exhaustive combinatorial usage of alternative splice insertions
in Nrxn1a and Nrxn2a that results in expression of at least 719
distinct Neurexin-1 and -2 protein isoforms. By contrast, we
identified for Nrxn3a specific stereotyped alternative exon com-
binations. These stereotyped events reduce the Nrxn3a isoform
diversity from potentially 11,520 variants to only about 645 iso-
forms that can be detected in the adult brain. Examination of
the invariant sequence elements in Nrxn3a reveals translational
control elements in the 30 UTR, providing a functional rationale
for the observed selectivity. Finally, we provide evidence that
Nrxn1a transcript diversity is linked to the cellular complexity
of brain regions and that a purified neuronal cell type exhibits a
strong enrichment of specific isoforms.
RESULTS
Development of a Workflow for Deep Single Molecule
Sequencing Analysis
The two major challenges with dissecting molecular diversity
are obtaining sufficient depth in long-range single molecule
sequencing and accurately mapping PacBio sequencing reads
to the original transcripts. For a pilot experimentNrxn1a,Nrxn1b,
Nrxn2a, Nrxn2b, Nrxn3a, and Nrxn3b complementary DNAs
(cDNAs) amplified from adult mouse cortex were pooled in equi-
molar amounts and subjected to sequencing. Sequencing of this
library yielded 648,549 subreads with a mean subread length of
1,091 base pairs (bp) (Figure S1A available online). Despite theequimolar presence ofNrxna andNrxnb transcripts in the library,
the shorter Nrxnb transcripts were more than 10-fold overrepre-
sented as compared to the longer Nrxna counterparts. This sug-
gests a more effective capture of shorter transcripts in the zero
wavelet guide cells. For Nrxn1b and Nrxn2b, all combinations
of alternative splice insertions at AS4 and AS5were detected, re-
sulting in four 1b and four 2b variants. For Nrxn3b, 29 of the 60
possible variants were detected (Figures S1B–S1D). This lack
of certain exon combinations is largely driven by the low abun-
dance of transcripts containing variants of alternative exon 24
that are detected in only 0.5% of all Nrxn3b transcripts.
The sequencing coverage for Nrxna isoforms (total of 3,324
full-length reads) is not sufficient for quantitative analysis of
Nrxna molecular diversity. The current estimates of potential
Nrxna isoform numbers are 574, 384, and 5,760 for Nrxn1, -2,
and -3, respectively (Tabuchi and Su¨dhof, 2002; Baudouin and
Scheiffele, 2010; Treutlein et al., 2014). In case of an equal rep-
resentation of all variants, the minimum sequencing depth
required to comprehensively cover this diversity is 3,000–
4,000 reads for Nrxn1a and -2 and approximately 40,000 reads
for Nrxn3a (Figure S2A). However, for the unequal distribution,
which exists in biological samples, even higher depth is required.
Thus, we wanted to develop a new workflow that would enable
sequencing tens of thousands of Nrxna full-length transcripts.
We isolated 100,000 Nrxn1a, 100,000 Nrxn2a, and 150,000
Nrxn3a independent, full-length cDNA clones from adult mouse
brain RNA. Clones were pooled in Nrxn1a -, Nrxn2a-, and
Nrxn3a-specific plasmid-based libraries, which were then sepa-
rately subjected to PacBio sequencing analysis (Figure 1A). For
the Nrxn1a samples, we generated from two independent
sequencing runs 88,531 and 186,394 postfilter subreads span-
ning full-length transcripts; 108,632 and 142,510 were obtained
for the Nrxn2a and Nrxn3a libraries, respectively. The statistics
relative to the sequencing runs are fully summarized in Table 1.
Our strategy to inspect the transcriptional landscape of the
Nrxn genes consisted of two steps: first, we focused on the pre-
existing gene models (Tabuchi and Su¨dhof, 2002; Baudouin and
Scheiffele, 2010; Treutlein et al., 2014) by generating, for each of
the three genes, an artificial transcriptome that comprises all the
possible transcripts arising from the combination of the known
exons according to their constitutive or alternative roles (see
Experimental Procedures). This in silico set of Nrxn mRNA con-
sists of 576 Nrxn1a transcripts, 384 Nrxn2a transcripts and
5,760 Nrxn3a transcripts, respectively. Reads putatively cov-
ering full-length transcripts, as identified by their length and the
presence of 50 and 30 sequences used to amplify the full-length
cDNAs, are then mapped onto the artificial transcriptome. We
directly compared two different types of alignments to the artifi-
cial transcriptome: BLASR, the native PacBio aligner (Chaisson
and Tesler, 2012), and BLAST (Altschul et al., 1990). The high de-
gree of similarity among some of the isoforms transcribed across
the Nrxn gene family causes the query read (PacBio subread) to
be easily aligned to more than one subject read (transcript). To
maximize accuracy of the mapping procedure, we leveraged
multiple alignment measures for assessing the quality of the
match (see Experimental Procedures for details).
When comparing results from BLASR and BLAST mapping
procedures, we found that both produced highly similar resultsNeuron 84, 386–398, October 22, 2014 ª2014 Elsevier Inc. 387
Figure 1. Deep Single Molecule Sequencing of Nrxna Transcripts
(A) Experimental workflow: cDNA for Nrxna was amplified from plasmid-based libraries, ligated to SMRTBell adapters, and subjected to SMRT sequencing
(SMRT-Sequ.). Full-length continuous long reads (CLRs) were aligned to an in silico transcriptome, unaligned reads were aligned to the genome for identification
of novel splice events, followed by experimental validation.
(B) The squared Pearson’s correlation coefficient (R2) is calculated on log-transformed sequence counts. To include isoforms only detected in one sample, we
added a baseline value of 0.5 to the sequencing count of each isoform.
(C) Validation of BLAST- and BLASR-based mapping results for Nrxn1a, -2a, and -3a. Inclusion frequencies extracted from the PacBio sequencing data were
compared to those calculated from semi-qPCR using primer pairs flanking each of the alternatively spliced segments (AS1–AS6). Alternative exon insertions were
considered en block, i.e., distinguishing only the presence or absence of alternative exons, as some alternative exon variations can not easily be distinguished.
(D) Depiction of predicted and observed variant numbers. Green circles: detected transcripts. Orange circles: transcripts predicted based on the existing data.
The maximal isoform numbers (max) were calculated based on exhaustive combinatorial use of all alternative splice insertions.
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Molecular Diversity of Neurexinsfor Nrxn1a and Nrxn2a, whose gene model allows for a relatively
limited number of transcripts (Figure 1B). However, mapping re-
sults significantly diverged for Nrxn3a transcripts, presumably
due to the complexity of the putative Nrxn3a isoform landscape
(Figure 1B). BLASR often gives rise to several candidate tran-
scripts being assigned to the same read with identical scores.
Thus, we hypothesized that there might be a higher rate of mis-
mapping with the BLASR algorithm. Performance of the two
alignment methods was evaluated by conducting a systematic
experimental validation of alternative exon incorporation rates
(Figure 1C). These experiments confirmed close correlation of
incorporation rates for transcripts mapped using the BLAST al-
gorithm but significant divergence for BLASR-based mapping
of Nrxn3a transcripts. Thus, we carried out all further analyses
using BLAST. Exon incorporation rates determined for our li-
braries were very similar, regardless of whether full-length reads
or circular consensus (CCS) reads were used for BLAST-based
analysis (Figures S1E and S2B). Moreover, incorporation rates388 Neuron 84, 386–398, October 22, 2014 ª2014 Elsevier Inc.correlated well with incorporation rates deduced from second-
generation sequencing obtained for cDNAs that had not gone
through the cloning steps involved in the library preparation
(Figure S2C). Finally, we applied a spliced mapper, GMAP
(Wu and Watanabe, 2005), to screen the full chromosomes in
an unbiased way and to identify genomic coordinates of poten-
tial novel exons and/or previously unknown acceptor-donor
sites.
Usage of Alternative Exons: Maximal Molecular
Diversification of Nrxn1a and Nrxn2a and a Narrow
Nrxn3a Isoform Landscape
Using the BLAST mapping approach, we identified 399 Nrxn1a,
320 Nrxn2a, and 645 Nrxn3a isoforms in the total brain libraries
(Figure 1D). Thus, in this complex sample, the vastmajority of the
possible combinations of alternative exons are detected for
Nrxn2a (83%), and a substantial fraction thereof is also detected
for Nrxn1a (69%) (Figure 1D). For Nrxn1a and Nrxn3a (but not
Table 1. Sequencing and Mapping Results
Sample
Nrxn1a Nrxn2a Nrxn3a
Total/AverageaWhole Brain #1 Whole Brain #2 Cereb. Cortex Granule cell Whole Brain Whole Brain
SMRT cells 3 3 3 3 3 3 6 24
Postfilter
Reads 169,978 332,667 225,797 235,206 272,276 256,716 371,485 1,864,125
Mean read length 4,412 4,583 4,141 3,854 4,917 4,386 4,765 4,437a
Mean read quality 0.853 0.837 0.852 0.849 0.843 0.849 0.847 0.847
Subreads 300,540 666,973 420,319 382,482 674,008 505,402 870,640 3,820,364
Mean subread length 2,474 2,261 2,202 2,351 1,957 2,204 2,006 2,208a
Mean subread N50 3,598 3,085 3,068 3,350 2,723 3,051 2,592 3,067a
Subreads, full transcripts 88,531 186,394 90,345 92,296 129,836 108,632 142,510 838,544
Unique Alignments
BLAST 49,005 71937 46,137 51,106 46,045 50,954 57,870 373,054
BLASR 53,127 81885 50,620 56,286 51,315 55,709 30,652 379,594
CCS reads 18,388 39,752 25,965 18,318 28,873 36,615 75,718 243,629
CCS full transcripts 12,215 18,210 10,744 11,159 2,578 17,520 20,500 92,926
Summary of libraries and SMRT cell sequencing runs obtained for Nrxn1, -2, and -3a libraries. Libraries were derived from cDNAs isolated from whole
brain, cerebellum (Cereb.), cortex, or purified cerebellar granule cells. The whole brainNrxn1a library was sequenced andmapped in two independent
runs (#1 and #2) to assess reproducibility of the procedure.
aTotal read and alignment counts and average read lengths, respectively.
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Molecular Diversity of NeurexinsNrxn2a), we observed an alternatively spliced segment that we
refer to as AS6 (Figure S3B). The same segment was also
described in a recent report (Treutlein et al., 2014). Moreover,
in Nrxn3a, we identified an additional novel alternative splice
acceptor site at AS3, which adds six bases to the constitutive
exon 12 (Figure S3A). Notably, this site is observed in the major-
ity of Nrxn3a mRNAs in the adult brain.
We further confirmed frequency of the novel AS6 insertions in
Nrxn1a and Nrxn3a by quantitative PCR (qPCR). This confirms
that AS6 insertions are indeed detected in 10% and 15%,
respectively, of Nrxn1a and Nrxn3a whole brain cDNAs, which
is in good accordance with our BLAST isoform mapping data
(Figure S3C). Interestingly, AS6 is differentially regulated in
Nrxn1a andNrxn3a over developmental stages and across brain
areas (Figure S3D) and is evolutionarily conserved in mammalian
and nonmammalian vertebrates (Figure S3E).
Strikingly, the observed Nrxn3a diversification is far below the
mathematically possible number of permutations (Figure 1D).
The theoretical maximal isoform number is 11,520mRNAs. How-
ever, only 645 isoforms (6%) were detected using our libraries
and sequencing approach (>140,000 full-length reads for
Nrxn3a). We consider it unlikely that this significant underre-
presentation of isoform diversity is a consequence of insuffi-
cient sequencing depth (see Supplemental Information for
sequencing depth simulations). Instead, we observed highly
restricted alternative exon permutations at AS3 and AS5 that
strongly limit the number of variants generated. For example,
99% of detected transcripts contain the novel splice acceptor
site at AS3, and only few variants contain the previously reported
acceptor (see Figure 3A). In summary, our single molecule deep
sequencing approach identifies novel alternative splice variants
and highly combinatorial alternative exon use, but also specific
stereotyped restrictions in alternative exon combinations. Thetotal repertoire of Nrxna isoforms detected by our approach in
the adult mouse brain consists of approximately 1,400 unique
mRNAs.
Quantitative Assessment of Isoform Enrichments in
the Total Nrxn Repertoires
A major question for interpreting single molecule long-read
sequencing data is the reproducibility of quantitative differences
in data sets. We examined the correlation of isoform counts
obtained from two independent sequencing runs for the same
Nrxn1a library. Overall, correlations were high (R2 = 0.92; Fig-
ure S2E) but became significantly weaker (R2 < 0.5) for isoforms
to which fewer than 18 reads were assigned. Thus, we used 18
reads as a lower threshold for quantitative analysis of isoform
representations. A striking observation is the differential distribu-
tion of relative isoform abundance among the three Nrxn genes
(Figure 2A). ForNrxn1, -2, and -3, the 20most abundant isoforms
represent 59%, 51%, and 69% of the total repertoire, respec-
tively (Figure 2B). Nrxn2a shows a much broader, more evenly
distributed repertoire of variants (Figure 2A). This large array of
significantly expressed variants strongly suggests that these
are not by-products of imprecise alternative splicing regulation
but rather that they contribute to cellular functions. By contrast,
Nrxn3a shows a strong bias toward a small number of variants
that contribute a large fraction of the repertoire, despiteNrxn3a’s
potential of deploying the largest extent of molecular diversity
(Figure 2A). Notably, only two Nrxn3a isoforms make up 27%
of all Nrxn3a transcripts, which differ only by the inclusion of
exon 4 at AS1 (Figure 2B). Finally, the sites of alternative exon
incorporation that drive diversity in the most abundant isoforms
differ for Nrxn1, -2, and -3. This suggests that alternatively
spliced segments in Nrxn1, -2, and -3 underlie differential regu-
lation by the splicing machinery.Neuron 84, 386–398, October 22, 2014 ª2014 Elsevier Inc. 389
Figure 2. Quantitative Analysis of Nrxn1, -2, and -3a Transcript Landscapes
(A) The relative contributions to the total repertoire is plotted for all reliably quantified Nrxna transcripts (R18 reads). Isoforms are ordered by rank. Dashed line
shows expected representation for an equal distribution ofNrxn variants andmaximal number ofNrxna variants (in this case, every variant will be represented at a
frequency of 0.17% for Nrxn1a, 0.26% for Nrxn2a, and 0.008% for Nrxn3a; the line for Nrxn3 is not shown, as it cannot be resolved at this scale).
(B) Alternative splice insertions and relative contributions of top 20 ranked Nrxna transcripts. Exons are color coded for constitutive (const.) exons (gray),
alternative (alt.) exons (red), alternative donor or acceptor sites in constitutive exons (pink), and alternative donor or acceptor sites in alternative exons
(orange).
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in Nrxn Diversity
To characterize potential linkage between individual exons in the
Nrxna mRNAs, we computed transition probabilities of consec-
utive exons and searched for dependencies in the exon usage
pattern of alternative exons (see Experimental Procedures). Fig-
ure 3A shows ‘‘spliceograms,’’ which display alternative exon
abundances in the form of inclusion frequencies within the entire
transcriptome (illustrated by the height of the alternative exons)
and transition probabilities that report the combination probabil-
ity of two consecutive exons within a transcript (illustrated by the
thickness of the connecting lines). AS1 represents a complex
segment composed of three alternative exons (exons 2, 3, and
4 with one alternative acceptor site in exon 2) that can be
included in various combinations. On inspection of Nrxn1a tran-
script variants, we observed tight coupling between the three
alternative exons (2, 3, and 4) of AS1, which were mostly incor-
porated either en block, i.e., distinguishing only the presence
or absence of alternative exons, or skipped altogether (72%
contain exons 2, 3, and 4; in 13.4%, all three exons are skipped).
By contrast, in Nrxn2a, the alternative exons at AS1 did show
less coupling (30% coinsertion of all three exons; 16% have no
insertions at AS1) and appeared often to be used independently
of each other (see Figure S4A for experimental validation). For
Nrxn3a, all three exons at AS1 were coinserted in 53% of tran-390 Neuron 84, 386–398, October 22, 2014 ª2014 Elsevier Inc.scripts, and exons 2 and 3 were frequently coinserted (88%),
whereas exon 4 acted somewhat disconnectedly (detected in
56%) (Figure 3A; Figure S4A). Thus, Nrxn2a is the gene that le-
verages the most complex interplay of alternative exons 2, 3,
and 4 in order to augment its isoform diversification. On the other
hand, Nrxn1a almost treats the block as a unique alternative
exon.
We performed a statistical evaluation of transcript repertoires
to identify potential long-range coupling of alternative splicing
eventsacrossdifferent alternatively spliced segments (Figure3B).
To minimize false-positives in this analysis, we reduced potential
noise by only including transcripts detected with at least 18
reads. The inspection of the results revealed statistically signifi-
cant coupling of specific alternative exon insertions at AS1 and
AS2 in all three Nrxna mRNAs. In Nrxn1a and -3, we observed
further selective coupling between insertion frequencies at AS6
with AS2 and AS4. In Nrxn2, the alternative exon 20 insertion at
AS4 was more frequently observed in combination with the 23b
acceptor site at AS5, whereas the 23a acceptor was significantly
underrepresented in these transcripts. Finally, the most striking
example of biased exon incorporation is observed for Nrxn3
AS5, where exon 24a insertions are almost invariantly connected
with exon 25a but not with 25b and -c splice acceptor sites of the
downstream exon (see Figure 6B for experimental validation).
The coupling events uncovered in our analysis suggest that
Figure 3. Short-Range and Long-Range Exon Coupling Events Detected in Single Molecule Sequencing Data
(A) Spliceograms of Nrxna transcripts. The inclusion frequencies of alternative exons and usage of alternative donor/acceptor sites are indicated by the height of
the rectangles and by the numbers above them. The transition probabilities are indicated by the thickness of the lines according to the key shown on the right.
const., constitutive; alt., alternative.
(B) Pairwise analysis of potential long-range coupling between splicing events (upper panel) and statistical analysis (lower panel). For this analysis, only transcripts
detected with at least 18 reads were used. Matrices on the upper row display the log2 ratio of Fobs over Fexp, where Fobs is the observed coupling frequency of two
exons and Fexp is their expected (exp.) coupling frequency. Fexp = FobsExonA , FobsExonB, where FobsExonX is the observed (obs.) frequency of an individual exon. The
matrices compare all constitutive and alternative exons. The rows displaying results for alternative sites are marked with exon numbers. The second row of
matrices presents the statistical significance of each log2 ratio. The p values were calculated using a chi-square test.
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gulated either through a common splicing program or through
systematic coexpression of multiple independent regulatory
factors in vivo. Moreover, the targeted combinatorial exon use
in Nrxn3a explains, to a large extent, the substantial limitation in
observed isoforms, with 645 observed variants versus the poten-
tial diversity of 11,520 variants.Neurexin Diversity Correlates with Neuronal Cell Type
Complexity
A major question regarding the function of highly diversified re-
ceptors is whether their diversity is linked to cellular diversity or
rather results from stochastic isoform choices (Schreiner et al.,
2014). To address this issue, we explored whether different brain
regions and purified cells would differ in isoform content.Neuron 84, 386–398, October 22, 2014 ª2014 Elsevier Inc. 391
Figure 4. Comparison of Nrxn1a Variant Abundance in Different Brain Regions and Purified Cells
(A) Correlation analysis of log-transformed sequence counts for Nrxn1a transcripts detected in different brain regions. A baseline value of 0.5 was added to the
sequencing count of each isoform detected only in one sample.
(B) Comparison of Nrxn1a variants detected in postnatal day 35 mouse cortex, cerebellum, or purified cultured granule cells (5 days in vitro). Proportional Venn
diagrams demonstrating total number of identified variants. Overlapping and nonoverlapping areas demonstrate common and unique variants, respectively.
(C) Relative representation of 50 top ranked variants plotted for cortex (orange), cerebellum (green), and cerebellar granule cells (blue).
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Molecular Diversity of NeurexinsFollowing the same workflow we have adopted for mRNAs ex-
tracted from whole brain tissue, Nrxn1a libraries from adult
mouse cortex, mouse cerebellum, and purified cultured cere-
bellar granule cells were analyzed. The amount of data retrieved
from the sequencing of the mRNA extracted from these tissues
is comparable with that of whole brain (Table 1). Notably, the rela-
tive isoform distributions and overall complexity of the Nrxn1a
repertoires were significantly different in the cerebellum as
compared to the cortex or whole brain (Figure 4A). Thus, this
simpler brain structure that is composed of fewer neuronal cell
types, exhibits a less varied repertoire of neurexins (Figure 4A).
The total number of detectable isoforms in cerebellar granule
cell libraries (208) is 59%of that observed in the cortex (354) (Fig-
ure 4B). The most drastic difference between the purified cell
preparations versus the cortical tissue is seen in the relative abun-
dances of themajor isoforms: in cerebellar granule cells, themost
abundant isoform represents 23% of the total Nrxn1a pool (Fig-
ure 4C). By contrast, the most highly expressed transcript in cor-
tex reaches only 6%. (Figure 4C). Moreover, 10 variants make up
76%of the totalNrxn1a repertoire in granule cellswhereas the top
ten variants in the cortex contribute only 36% of the total reper-
toire (Figure 5A). Finally, exon incorporation rates and transition
probabilities differ between the different neuronal populations
(Figure 5B). These observations strongly support the model that
there are cell type-specific Nrxna repertoires in the mammalian
brain. At the same time, purified cells still express a significant
number of different variants, suggesting either coexpression of392 Neuron 84, 386–398, October 22, 2014 ª2014 Elsevier Inc.multiple variants per cell or molecular heterogeneity of the Nrxna
repertoires across different cells in the purified cell population.
Targeted Alternative Exon Insertion Limits Molecular
Diversity of Nrxn3a
The majority of theoretically possible Nrxn1a and Nrxn2a tran-
scripts could be detected, but only 6% of Nrxn3a variants were
recovered in our transcript analysis. The in-depth examination
of coupling events uncovered several strongly biased alternative
exon incorporation events that greatly restrict Nrxn3 diversity.
The strongest isoform bias is observed for AS5, a complex alter-
natively spliced segment with multiple alternative donor and
acceptor sites (Figure 6A). The constitutive exon 23 contains
two alternative donor sites (23a and 23b). The downstream alter-
native exon 24 contains four alternative acceptor sites (24a, -b, -c,
and -d) and a single donor site. Upstream exons 23 and the alter-
native exon 24 can each be linked with three alternative acceptor
sites in the downstream constitutive exon 25 (25a, -b, and -c).
Interestingly, transcripts lacking exon 24 (AS5) show varied
use of exon 23donor and exon 25 acceptor sites (6%–77%usage
for each of the sites). By contrast, the detected AS5+ transcripts
(containing exon 24) exhibit a stereotyped exon incorporation
pattern. The vast majority of AS5+ transcripts contain acceptor
site 24a and acceptor site 25a, a pattern that we confirmed ex-
perimentally with semi-qPCR (Figure 6B). Thus, the substantial
molecular diversity that could arise from combinatorial AS5 alter-
native splice site usage is largely undetected in the adult brain.
Figure 5. Brain-Region-Specific Repertoires of Nrxn1a Variants
(A) Block diagrams illustrating differences in relative contribution and splice variants of the top 10 ranked Nrxn1a transcripts in cortex, cerebellum, and purified
granule cells. Color coding is as in Figure 2 (and as illustrated below). Height of individual blocks is proportional to the relative contribution of the transcript to the
total pool of detected Nrxn1a transcripts.
(B) Spliceograms for Nrxn1a transcripts detected in different brain areas. The average frequencies of alternative (alt.) exon inclusions (red) are symbolized by the
height of rectangles and are indicated with numbers above. Transition probabilities are indicated by the thickness of the connecting lines. const., constitutive.
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codon that was proposed to result in secreted forms of Nrxn3a
(Ushkaryov and Su¨dhof, 1993). Moreover, the premature stop
is predicted to target these transcripts for nonsense-mediated
decay (Giorgi et al., 2007). The preferential use of ex24a and
ex25a acceptor sites generates an invariant 30 UTR for this
class of Nrxn3 transcripts. We hypothesized that this 30 UTR
may confer a specific function that contributes to the re-
gulation of AS5+ isoform expression. When fused to a green
fluorescent protein (GFP) reporter open reading frame, exon
24a-25a 30 UTR sequences silenced translation of the GFP re-
porter without significantly altering transcript levels (Figure 6C).
Efficient translational repression was dependent on the pres-
ence of exon 24a sequences and was completely lost upon
removal of exons 24a, 24b, and 24c, and exon 25a. Reporter
fusions containing only exon 24a, or exons 24a and 25a in
combination, result in a substantial degree of translational
silencing. Thus, our single molecule sequencing analysis
identifies a regulatory element in the 30 UTR of Nrxn3 that is
sufficient for posttranscriptional regulation of specific neurexin
transcripts.DISCUSSION
Molecular diversity resulting from alternative splicing has been
implicated in neuronal self-recognition, functional tuning of ion
channel properties, and selective trans-synaptic interactions en-
coded by cell surface proteins (Lipscombe, 2005; Zheng and
Black, 2013; Schreiner et al., 2014). A key concern regarding
the functional logic of such receptor systems is their coding
power, which is dependent on the number of distinct variants ex-
pressed in the nervous system. We demonstrate that Nrxn iso-
form repertoires are biased toward certain highly represented
variants. This preferential isoforms usage acts differently among
the three members of the gene family and shows distinct pat-
terns across various brain regions. Purified cells of one morpho-
logically defined cell type exhibit a significant enrichment of spe-
cific isoforms but continue to express a complex set of variants.
Actual Molecular Diversity of Nrxna Transcripts
Detected in the Adult Brain
The application of a novel workflow in this study was essential to
accomplish deep single molecule sequencing of the neurexinNeuron 84, 386–398, October 22, 2014 ª2014 Elsevier Inc. 393
Figure 6. mRNAs Encoding Secreted Nrxn3 Variants Contain a Translational Silencing Element
(A) Selective spliceograms of Nrxn3 AS5 for transcripts containing (AS5+) or lacking (AS4) exon 24. Color coding is as indicated. const., constitutive; alt.,
alternative.
(B) Confirmation of selective alternative splicing patterns of Nrxn3a by PCR performed on total mouse brain cDNA (postnatal day 35).
(C) Assessment of Nrxn3a AS5+ 30 UTR functions. HEK293 cells were transfected with plasmid DNA encoding a reporter consisting of GFP coding sequence
followed by a translational stop codon and fused to different variants resulting from alternative exon incorporation at Nrxn3 AS5. At 24 hr posttransfection, GFP
fluorescence was assessed in a fluorimeter (bar diagram, mean and SD) or by western blot with an anti-GFP antibody. Transcript level of the constructs was
measured by RT-PCR (bottom left).
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Molecular Diversity of Neurexinsgene family. A previous application of third generation se-
quencing covered Nrxn1a and 3a transcripts with a total of
3,508 reads (Nrxn2 was not analyzed) (Treutlein et al., 2014).
This limited sequencing depth is 4-fold below the number of po-
tential variants. Consequently most variants remained unde-
tected andmany detected variants were covered by only a single
read (Treutlein et al., 2014). These limitations preclude a rigorous
assessment of the actual isoform diversity and statistical evalu-
ation of combinatorial splicing events. The plasmid-based library
approach applied here was a key step toward significantly
improved sequencing depth. Moreover, our use of an in silico
generated, artificial transcriptome has the advantage to directly
assign each read to a transcript. This avoids isoform reconstruc-
tion, which is required when spliced mappers such as STAR
(Dobin et al., 2012) are used. In our case, both the query and
the subject sequences are treated in an end-to-end mode, cir-
cumventing the need for intronic read splitting. Furthermore, it
gives a precise estimate of how many possible isoforms one
has to expect and consequently aids the experimental design,
particularly with respect to the targeted sequencing depth.
One finding that stands out from our results is the almost
exhaustive use of combinatorial exon use in Nrxn2a. At the
same time, Nrxn2a transcripts distribute most uniformly across
the potential isoforms. Thus, a large number of variants is not
only detectable but also significantly represented in the total
transcriptome. By contrast, Nrxn3a transcripts do not reach
the theoretically possible combinatorial diversity. Based on the
transition probabilities at individual alternative splice sites, we
calculated the abundance of nondetected isoforms and simu-
lated the sequencing depth required to recover nondetected iso-
forms. This analysis suggests that the nondetected isoforms
make up only 2.17% of the total Nrxn3 transcriptome (0.46%
and 0.05% for Nrxn1 and -2, respectively). Moreover, the simu-
lations indicated that even a 3-fold increase in sequencing depth
would only result in a very small increase in the number of de-
tected variants (Figure S5). Thus, only very rare, significantly un-
derrepresented transcripts are likely to escape identification.
Notably, we find that stereotyped codetection of specific exons
in Nrxn3 AS5+ transcripts is a specific driver of the reduced mo-
lecular diversity of Nrxn3a. By contrast, we do detect extensive
combinatorial exon use at the majority of other alternatively
spliced segments. This further supports the conclusion that the
limited use of Nrxn3a combinatorial diversity is due to targeted
regulatory mechanisms rather than a general inability to detect
variants due to low sequencing depth.
Posttranscriptional Regulation of Nrxn3 Isoforms
Sequencing at high depth enabled us to deconstruct the inter-
play among alternative exons in Nrxn3 AS5, which led to the
discovery of a posttranscriptional regulation element in the non-
coding 30 UTR. Nrxn3 AS5+ transcripts containing exon 24 (a, b,
c, and d) are predicted to target the Nrxn3 mRNA for nonsense-
mediated decay (Giorgi et al., 2007). We demonstrate that exon
24a-exon 25a-containing mRNAs represent a substantial frac-
tion of Nrxn3a transcripts (14%). In functional experiments, we
demonstrate that exon 24a-exon 25a sequences encode a
powerful translational silencing element that is required and
sufficient for translational silencing of a reporter mRNA. Thus,our analysis identifies an element for posttranscriptional regula-
tion of Nrxn3. We speculate that translational silencing protects
Nrxn3-24a/25a mRNAs from nonsense-mediated mRNA decay
and provides a mechanism for temporally and spatially
controlled expression. Surprisingly, we observed that Nrx3
AS5+ proteins that lack the Nrx3 transmembrane domain are
not secreted as it was previously proposed (Ushkaryov and Su¨d-
hof, 1993). Epitope-tagged Nrx3 AS5 protein was distributed
across the plasma membrane of transfected COS7 cells; was
not detectable in the culture medium; and was, instead, strongly
enriched in membrane fractions (Figures S6A and S6B). More-
over, the Nrx3 AS5 protein could be released from membranes
by treatment with phosphatidylinositol-specific phospholipase
C, strongly suggesting that the protein is linked to the outer
leaflet of the plasma membrane via a GPI anchor. Thus, the
amino acids encoded by AS5 result in an alternative mode of
membrane anchoring of these Nrx3 isoforms.
Another notable outcome from our coupling analysis concerns
novel alternatively spliced segment AS6, which exhibits substan-
tial developmental and region-specific regulation. Structural
predictions position this insertion site at a kink between Laminin
G-domain 5 and epidermal growth factor-domain 3 of the
L-shaped Nrx1a structure (Chen et al., 2011; Miller et al., 2011;
Treutlein et al., 2014) (Figure S4). AS6 insertions are correlated
with splice insertions at AS4, a site that may modify the coordi-
nation of ligands in the closed, L-shaped Nrx1a protein confor-
mation (Figures S6C and S6D). Thus, coordinated splicing
events at multiple sites may tailor Nrx1a structure for specific
ligand interactions.
Isoform Repertoires in Different Brain Regions and
Cell Populations
Our comparison of neurexin repertoires in different brain regions
and purified cells suggests a correlation between the cellular
complexity and the complexity of the neurexin repertoire. We
observed a strong enrichment of certain dominant isoforms in
purified cerebellar granule cells, and the total number of signifi-
cantly detected isoforms was reduced. However, even in the pu-
rified cell population, a substantial heterogeneity remains. It
should be noted that template switching of reverse transcriptase
and cross-hybridization of templates during PCR amplification
can artificially link exons from different transcripts (Meyerhans
et al., 1990; Houseley and Tollervey, 2010). We tested experi-
mentally the extent of artificial exon combinations arising from
PCR amplification for Nrxna templates and concluded that this
occurs only at a low frequency (5.2%) under our experimental
conditions (Figure S2D). Thus, we cannot exclude that some of
the low level isoforms detected in purified granule cells arose
from such artificial exon combination events.
In summary, our results suggest that Nrxn1a repertoires are at
least partially linked to cell identity. The logic of Nrxn splice iso-
form expression appears to be fundamentally different from the
probabilistic isoform choices observed for DSCAM, a highly
diversified receptor in the Drosophila nervous system (Miura
et al., 2013; Schreiner et al., 2014). This notion is further sup-
ported by the cell-type-specific expression of RNA-binding
proteins that regulate Nrxn alternative splicing (Iijima et al.,
2014). Our mapping of neurexin diversity strongly supportsNeuron 84, 386–398, October 22, 2014 ª2014 Elsevier Inc. 395
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native splicing programs. The methodologies established here
can be applied to genetically and/or anatomically defined cell
populations to test more rigorously the association of specific
neurexin isoforms with unique functional or morphological prop-
erties of neurons. Moreover, this approach provides an opportu-
nity to dissect posttranscriptional processing of other complex
gene families at the single cDNA level.
EXPERIMENTAL PROCEDURES
Library Preparation and Sequencing
RNA from whole brain or dissected brain regions from mice (postnatal day 35)
or cultured cerebellar granule cells (maintained in vitro for 5 days) was pre-
pared using the RNeasy Mini Kit (Qiagen). One to two micrograms of total
RNA were used for the first strand synthesis. Reverse transcription was per-
formed using SuperScript III Reverse Transcriptase (Life Technologies) with
a mix of gene-specific primers that bind in the 30 UTR of the particular
mRNA. The mix contained five gene-specific primers, 2 mM each. Reverse-
transcribed RNA was used for the amplification of the cDNA using Phusion
DNA polymerase. Gene-specific primers that anneal in the first and the last
coding exons were used for cDNA amplification. PCR products corresponding
to the full-length cDNA (4,000 bp) were excised from agarose gels, ligated
into Zero-Blunt TOPO vector, and transformed into MegaX DH10B T1 Electro-
comp cells (Invitrogen). Bacteria were plated at a density of 2,500–3,000
colonies per plate to create a plasmid library containing 100,000–150,000 in-
dependent clones. Colonies were harvested, and plasmid DNA was isolated
using the Midi-Plasmid Isolation Kit (Qiagen). Subsequently, inserts were
amplified using M13-forward/M13-reverse or T3/T7 primers and purified using
a PCR purification kit (Qiagen). The double-stranded cDNA libraries were
completed by the ligation of the SMRTBell adapters (DNA/Polymerase Binding
Kit XL 1.0) and following the standard PacBio guidelines for preparing tem-
plates of 4–6 kb in size (PacBio DNA Template Prep Kit 2.0). The PacBio RS
was set up to produce movies 90 min long based on the C2 chemistry. All
animal procedures were approved by the Cantonal Veterinary Office of
Basel-Stadt.
The Artificial Transcriptome of the Mouse Neurexin Gene Family
To construct an exhaustive artificial transcriptome of the mouse genes
NRXN1–3, we represent each neurexin gene model as an acyclic-directed
graph G = (V, E), where each vertex v ˛ V corresponds to an exon ex, and
two vertices vi, vj ˛ V are connected by a directed edge e
! = (vi, vj) if and
only if the corresponding exons exi and exj occur consecutively in a neurexin
transcript. Subsequently, all maximal paths between source vertices (a/b pro-
moters) and sink vertices (terminal exons) are generated, and the correspond-
ingmRNA sequences are stored in FASTA format. When including novel exons
identified in this study, this procedure results in 576 Nrxn1a, 384 Nrxn2a, and
11,520 Nrxn3a transcripts, respectively.
Alignment of Analysis of the Filtered Subreads
The sequences produced by the PacBio RS II consist of reads (called polymer-
ase reads) that start and finish with the life span of the polymerase sitting at the
bottom of the nanowells. The length of these reads is essentially independent
of the fragment size; therefore, when the polymerase lives long enough to walk
along the entire fragment more than once, more than one subread per physical
fragment is reported. The subreads representing putative full transcripts and
that did not undergo the CCS refinement were subject to two different types
of alignments to the artificial transcriptome: BLASR, the native PacBio aligner
(Chaisson and Tesler, 2012) and BLAST (Altschul et al., 1990). BLASR was
used with default settings, and BLAST was used by requiring a minimum iden-
tity between the query and the subject reads of 80%. Both tools produce
tabular output formats incorporating a number of parameters, including the
numbers of matches and mismatches, percentage of identity between the
query and the subject reads, and a matching score, among others. Each
subread was first univocally assigned to a transcript following a two-step pro-396 Neuron 84, 386–398, October 22, 2014 ª2014 Elsevier Inc.cedure: first, the multiple alignments for all the subreads were resolved by se-
lecting the best match among the possible hits after they were ranked accord-
ing to the matching score, the percentage of identification, and the length of
the overlap, in this order. However, at this stage, multiple subreads coming
from the same reads were still present; therefore, for each set of subreads
generated by the same polymerase read, we repeated the same ranking pro-
cedure so that, in the end, each read (physical transcript) would correspond to
only one NRXN isoform. This way, we ensured that the abundance estimates
would not be inflated by counting more than one subread for each cDNA frag-
ment. In order to compare the results obtained with the non-CCS reads, the
same workflow was applied to the CCS reads, and the corresponding iso-
forms’ abundances were correlated with those calculated based on the
assignment of the non-CCS reads. The same workflow was applied starting
from the CCS reads. As for the discovery of novel exons, CCS reads were
instead mapped to the full corresponding chromosomes using the spliced
aligner GMAP (Wu and Watanabe, 2005).
Experimental validations were conducted by semi-qPCR, qPCR, and/or
DNA sequencing of DNA fragments.
Quantitative Analysis of Transcripts
Exon inclusion rates were calculated as follows: For exon e, denote t(e) as the
set of transcripts that include e and t(not e) as the set of transcripts that do not
include e. We compute the exon inclusion level as the fraction #t(e)/[#t(e)+#t
(not e)]. An exon inclusion level of 1 indicates a constitutive exon; exon inclu-
sion levels smaller than 1 indicate exon skipping.
Exon transition probabilities were assessed using a simple model of tran-
script generation that assumes that the probability of joining (splicing together)
two consecutive exons e1 and e2 can be modeled by an exon transition prob-
ability that only depends on e1 and e2. We estimated this probability by the
fraction #t(e1 and e2)/#t(e1). An exon transition probability between e1 and
e2 of 1 indicates that whenever exon e1 is observed, we also observe exon
e2; a transition probability of 0.5 indicates that, in 50% of the cases where
exon e1 is observed, we also observe exon e2.
Dependencies between exons were assessed using an approach similar to
the one described by Agnew and colleagues (Emerick et al., 2007). To describe
a transcript, we represent each splicing segment (exon) j in the genemodel by a
categorical variable C(j). Assume that the gene model comprises m splice seg-
ments and that there are gj exon variants at segment j, j = 1, . . . m. In this case,
C(j) has the possible value 0, indicating that exon j was skipped, or an integer i
between 1 and gj, indicating the presence of exon variant i in segment j. We
represent each transcript by its sequence of C(j) values, j = 1, . . . , m. To detect
a possible coupling between splicing segments k and l, we compute a contin-
gency table for C(k) and C(l) from our transcript set and perform Pearson’s chi-
square test and Bonferroni multiple testing correction to assess if the splicing
events at locus k are independent of the events at locus l.
To estimate the relative abundance of nondetected isoforms, the probability
of each isoform was calculated by multiplying the experimentally observed
transition probabilities of its constituting exons. For calculation of the relative
representation of nondetected Nrxna variants, the calculated relative abun-
dance of nondetected isoforms was summed.
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